05/14/2024
3:04 PM | Akebia Therapeutics (Issuer)
Dahan Michel (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/14/2024
3:05 PM | Akebia Therapeutics (Issuer)
Hadas Nicole R. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/13/2024
6:17 PM | Akebia Therapeutics (Subject)
Hadas Nicole R. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/13/2024
6:19 PM | Akebia Therapeutics (Subject)
Dahan Michel (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/09/2024
4:27 PM | Akebia Therapeutics (Issuer)
Burke Steven Keith (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/09/2024
6:03 AM | Akebia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/09/2024
6:05 AM | Akebia Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
|
04/25/2024
4:17 PM | Akebia Therapeutics (Filer)
| Form DEF 14A | |
04/25/2024
4:18 PM | Akebia Therapeutics (Filer)
| Form DEFA14A | |
04/25/2024
4:19 PM | Akebia Therapeutics (Filer)
| Form ARS | |
04/23/2024
7:32 AM | Akebia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/16/2024
6:33 AM | Akebia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/14/2024
4:19 PM | Akebia Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/01/2024
4:48 PM | Akebia Therapeutics (Issuer)
Hadas Nicole R. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/01/2024
4:49 PM | Akebia Therapeutics (Issuer)
Dahan Michel (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/01/2024
4:46 PM | Akebia Therapeutics (Issuer)
Burke Steven Keith (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/01/2024
4:47 PM | Akebia Therapeutics (Issuer)
Butler John P. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/29/2024
5:00 PM | Akebia Therapeutics (Issuer)
Butler John P. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/29/2024
5:01 PM | Akebia Therapeutics (Issuer)
Burke Steven Keith (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/29/2024
5:02 PM | Akebia Therapeutics (Issuer)
Dahan Michel (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/29/2024
5:03 PM | Akebia Therapeutics (Issuer)
Hadas Nicole R. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/29/2024
3:32 PM | Akebia Therapeutics (Subject)
Butler John P. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/27/2024
5:11 PM | Akebia Therapeutics (Subject)
Butler John P. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/27/2024
5:14 PM | Akebia Therapeutics (Subject)
Burke Steven Keith (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/27/2024
5:16 PM | Akebia Therapeutics (Subject)
Dahan Michel (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/27/2024
5:19 PM | Akebia Therapeutics (Subject)
Hadas Nicole R. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/13/2024
7:00 AM | Akebia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/01/2024
3:52 PM | Akebia Therapeutics (Subject)
Butler John P. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/01/2024
3:40 PM | Akebia Therapeutics (Subject)
Burke Steven Keith (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/30/2024
7:05 AM | Akebia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/18/2024
4:21 PM | Akebia Therapeutics (Issuer)
Grund Nicholas (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/18/2024
3:21 PM | Akebia Therapeutics (Issuer)
Malabre Richard C (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/08/2024
7:02 AM | Akebia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/21/2023
4:07 PM | Akebia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/08/2023
6:45 AM | Akebia Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/08/2023
6:33 AM | Akebia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/02/2023
3:34 PM | Akebia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/12/2023
7:31 AM | Akebia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/26/2023
3:47 PM | Akebia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/28/2023
7:55 AM | Akebia Therapeutics (Filer)
| Form 10-K/A | |
08/28/2023
7:57 AM | Akebia Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
Don’t buy Gold until you see this (Ad) Did you know gold has “hotspot dates” between December 12th - December 24th?
Meaning it’s gone up on average during those dates for the past 34 YEARS!
Most people probably have no clue about these dates unless they have access to this former hedge fund manager's Data Mining Software….
As you can see, it would have alerted you ahead of time that gold was gearing up for a big move between these dates. But if you want the stock with “Hotspot Dates” hitting NEXT WEEK… |
08/25/2023
7:14 AM | Akebia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/11/2023
6:35 AM | Akebia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/18/2023
3:30 PM | Akebia Therapeutics (Issuer)
Snow Ellen (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
07/18/2023
6:47 AM | Akebia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/13/2023
6:04 AM | Akebia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/08/2023
3:30 PM | Akebia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/07/2023
6:31 AM | Akebia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/02/2023
7:01 AM | Akebia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
